期刊文献+

硫酸乙酰肝素聚合物胶束的制备及其性能的研究

Preparation and Characterization of Heparan Sulfate-Based Copolymer Micelles
原文传递
导出
摘要 目的合成硫酸乙酰肝素-维生素E琥珀酸酯(heparan sulfate-vitamin E succinate,HDV)两亲性材料,包载多柔比星形成聚合物胶束,并对其制剂学性质进行考察。方法通过酰胺反应,合成HDV载体,利用核磁对其结构进行确证。选择超声法制备载多柔比星的聚合物胶束,考察胶束的粒径、形貌、电位、载药量、包封率以及体外释放行为,并对其体外细胞毒性进行了评价。结果成功地合成了HDV两亲性聚合物材料,制备的载药胶束平均粒径为(105.0±7.3)nm,PDI值为(0.239±0.484),电位值为(-21.4±2.6)m V,包封率为(76.22±0.76)%,载药量为(9.53±0.58)%;体外药物释放实验结果表明,载药胶束具有良好的缓释作用。细胞毒性实验显示,空白胶束对正常细胞和肿瘤细胞都几乎没有毒性,而载药胶束具有较好的抗肿瘤活性。结论 HDV聚合胶束可以有效地包载抗肿瘤药物多柔比星,具有良好的缓释特性和抗肿瘤活性,可作为一种潜在应用价值的抗肿瘤药物载体。 OBJECTIVE To prepare heparan sulfate-vitamin E succinate (HDV) amphipathic copolymers and explore the phar- maceutical properties of doxorubicin (DOX) -loaded HDV copolymer micelles ( DOX/HDV ). METHODS HDV copolymers were prepared by amide reaction and its structure was confirmed by i H-NMR. DOX/HDV micelles were prepared by ultrasonic method. The panicle size, morphology, Zeta potential, drug loading, entrapment efficiency, and in vitro drug release and cytotoxicity were evalua- ted. RESULTS HDV amphipathic copolymers were synthesized successfully. The particle size, PDI value and Zeta potential of drug- loaded micelles were (105.0±7.3) nm, (0. 239 ±0. 484) and ( -21.4 ±2.6) mV, respectively. The encapsulation and drug load- ing rate were (76. 22 ±0. 76)% and (9.53 ± 0. 58)%, respectively. The results of drug release test in vitro showed that DOX was released slowly from the micelles. Cytotoxicity experiments indicated that blank micelles had no apparent toxicity against both tumor cells and normal cells. However, DOX/HDV micelles could inhibit the tumor cells growth obviously. CONCLUSION HDV copoly- mers can effectively load DOX with properties of drug sustained release and enhanced cytotoxicity against tumor cells in vitro, which in- dicates that HDV may be a potential candidate for cancer therapy.
机构地区 江南大学药学院
出处 《中国药学杂志》 CAS CSCD 北大核心 2016年第15期1302-1307,共6页 Chinese Pharmaceutical Journal
基金 国家自然科学基金青年科学基金资助项目(81503007)
关键词 硫酸乙酰肝素 维生素E琥珀酸酯 聚合物胶柬 多柔比星 heparan sulfate vitamin E succinate copolymer micelle doxorubicin
  • 相关文献

参考文献3

二级参考文献28

  • 1刘浩,童旭辉,马连华,许诤,崔小岱,蒋志文.C_3H非自发性小鼠乳腺癌模型的建立[J].中国药理学通报,2005,21(11):1396-1398. 被引量:9
  • 2许向阳,李玲,周建平.聚合胶束载药多柔比星的研究进展[J].中国新药杂志,2007,16(1):28-32. 被引量:10
  • 3孙兴权,李静,耿美玉,管华诗.乳腺癌相关糖复合物糖链研究进展[J].中国药理学通报,2007,23(4):425-427. 被引量:8
  • 4Bernfield M, Gotte M, Park P W, et al. Functions of cell surface heparan sulfate proteoglycans [ J ]. Annu Rev Biochem 1999,68 : 729 - 77.
  • 5Fugedi P. The potential of the molecular diversity of heparin and heparan sulfate for drug development [ J ]. Mini Rev Med Chem, 2003,3(7 ) :659 -67.
  • 6Toi M, Hoshina S, Takayanagi T,Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer[J]. Jpn J Cancer Res, 1994,85(10) :1045 -9.
  • 7Tumova S, Woods A, Couchman J R. Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions [ J ]. Ira J Biochem Cell Biol, 2000,32(3 ):269-88.
  • 8Ferro V, Dredge K, Liu L, et al. PI-88 and novel heparan sulfate mimetics inhibit angiogenesis [ J ]. Semin Thromb Hemost, 2007, 33(5) :557 -68.
  • 9Basche M, Gustafson D L, Holden S N, et al. A phase Ⅰ biological and pharmacologic study of the heparanase inhibitor PI - 88 in patients with advanced solid tumors[ J]. Clin Cancer Res,2006,12 (18) :5471 -80.
  • 10Zhang Y, Li L, Wang Y, et al. Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma [ J ]. Biochem Biophys Res Commun,2007,355( 1 ) : 124 -9.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部